Literature DB >> 10523595

A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts.

L J Paoletti1, J Bradford, L C Paoletti.   

Abstract

Maternal colonization with group B Streptococcus (GBS) is a risk factor for neonatal GBS disease. Whereas serotypes Ia, Ib, II, III, and V are prevalent in the United States, types VI and VIII predominate in Japan. Recently, a serotype VIII strain was detected among 114 clinical GBS isolates from a Boston, Mass., hospital.

Entities:  

Mesh：

Year:  1999        PMID： 10523595      PMCID： PMC85754     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Neonatal sepsis caused by a new group B streptococcal serotype.

Authors:  M A Rench; C J Baker
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

2.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

3.  Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

Authors:  L C Paoletti; J Pinel; K D Johnson; B Reinap; R A Ross; D L Kasper
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

4.  Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection.

Authors:  F Y Lin; J D Clemens; P H Azimi; J A Regan; L E Weisman; J B Philips; G G Rhoads; P Clark; R A Brenner; P Ferrieri
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

5.  Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women.

Authors:  C S Lachenauer; D L Kasper; J Shimada; Y Ichiman; H Ohtsuka; M Kaku; L C Paoletti; P Ferrieri; L C Madoff
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

6.  Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; A K Rodewald; A A Shroff; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  M R Wessels; L C Paoletti; A K Rodewald; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 9.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1934-03-31       Impact factor: 14.307
View more
  9 in total

1.  Emergence of invasive serotype VIII group B streptococcal infections in Denmark.

Authors:  Kim Ekelund; Hans-Christian Slotved; Hans Ulrik Nielsen; Margit S Kaltoft; Helle B Konradsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Molecular characterization of nontypeable group B streptococcus.

Authors:  Srinivas V Ramaswamy; Patricia Ferrieri; Aurea E Flores; Lawrence C Paoletti
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 3.  Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Clin Microbiol Rev       Date:  2018-08-15       Impact factor: 26.132

4.  Type IV neonatal early-onset group B streptococcal disease in a United States hospital.

Authors:  Karen M Puopolo; Lawrence C Madoff
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

5.  Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.

Authors:  Hiroshige Mikamo; Atul K Johri; Lawrence C Paoletti; Lawrence C Madoff; Andrew B Onderdonk
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  DNA microarray-based typing of Streptococcus agalactiae isolates.

Authors:  Heike Nitschke; Peter Slickers; Elke Müller; Ralf Ehricht; Stefan Monecke
Journal:  J Clin Microbiol       Date:  2014-08-27       Impact factor: 5.948

7.  Serotype IX, a Proposed New Streptococcus agalactiae Serotype.

Authors:  Hans-Christian Slotved; Fanrong Kong; Lotte Lambertsen; Susanne Sauer; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

8.  Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution.

Authors:  Danielle L Ippolito; Wesley A James; Deborah Tinnemore; Raywin R Huang; Mary J Dehart; Julie Williams; Mark A Wingerd; Samandra T Demons
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

Review 9.  Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.

Authors:  Sarah Shabayek; Barbara Spellerberg
Journal:  Front Microbiol       Date:  2018-03-14       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.